Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

ClinicalTrials.gov ID: NCT03268005

Public ClinicalTrials.gov record NCT03268005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec With or Without Metformin in Adults With Type 2 Diabetes (Onset® 9)

Study identification

NCT ID
NCT03268005
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,264 participants

Conditions and interventions

Interventions

  • Faster-acting insulin aspart Drug
  • Insulin aspart Drug
  • Insulin degludec Drug
  • Metformin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2017
Primary completion
Jan 6, 2019
Completion
Jan 28, 2019
Last update posted
Jan 10, 2022

2017 – 2019

United States locations

U.S. sites
64
U.S. states
28
U.S. cities
59
Facility City State ZIP Site status
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Fullerton California 92835
Novo Nordisk Investigational Site Lancaster California 93534
Novo Nordisk Investigational Site Norco California 92860
Novo Nordisk Investigational Site Sacramento California 95821
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Denver Colorado 80246
Novo Nordisk Investigational Site Golden Colorado 80401
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Boynton Beach Florida 33472
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Fort Lauderdale Florida 33312
Novo Nordisk Investigational Site Miami Florida 33174
Novo Nordisk Investigational Site Tampa Florida 33634
Novo Nordisk Investigational Site Alpharetta Georgia 30022
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Peoria Illinois 61603
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Valparaiso Indiana 46383
Novo Nordisk Investigational Site West Des Moines Iowa 50266
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40502
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Worcester Massachusetts 01655
Novo Nordisk Investigational Site Henderson Nevada 89052-2649
Novo Nordisk Investigational Site Las Vegas Nevada 89148
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Chapel Hill North Carolina 27514
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104-5020
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19140
Novo Nordisk Investigational Site Greenville South Carolina 29605-4254
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Austin Texas 78749
Novo Nordisk Investigational Site Beaumont Texas 77701
Novo Nordisk Investigational Site Dallas Texas 75226
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Longview Texas 75605
Novo Nordisk Investigational Site Pearland Texas 77584
Novo Nordisk Investigational Site Round Rock Texas 78681
Novo Nordisk Investigational Site Ogden Utah 84405
Novo Nordisk Investigational Site Bennington Vermont 05201
Novo Nordisk Investigational Site South Burlington Vermont 05403
Novo Nordisk Investigational Site Chesapeake Virginia 23321
Novo Nordisk Investigational Site Winchester Virginia 22601-3834
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Seattle Washington 98105
Novo Nordisk Investigational Site Spokane Washington 99201
Novo Nordisk Investigational Site Green Bay Wisconsin 54303

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03268005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2022 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03268005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →